MHC class II, tumour necrosis factor α, and lymphotoxin α gene haplotype associations with serological subsets of systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 65, Issue 4, 2006, Pages 488-494

  McHugh, Neil J ^a,b   Owen, P ^b   Cox, B ^b   Dunphy, J ^b   Welsh, K ^c  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b Bath Institute for Rheumatic Diseases   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOTOXIN-ALPHA; MALE; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645116167     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.039842     Document Type: Article

References (44)

1. Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595-602.
2. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, et al. Systemic lupus erythematosus in three ethnic groups. I. The effects of HLA Class II, C4, and CR! alleles, socioeconomic factors, and ethnicity at disease onset. Arthritis Rheum 1998;41:1161-72.
3. Gladman DD, Urowitz MB, Darlington GA. Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 1999;8:466-70.
4. Hartung K, Baur MP, Coldewey R, Fricke M, Kalden JR, Lakomek HJ, et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest 1992;90:1346-51.
5. Arnett FC. Genetic studies of human lupus in families. Int Rev Immunol 2000;19:297-317.
6. Gordon C, Ranges GE, Greenspan JS, Wofsy D. Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol 1989;52:421-34.
7. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor-α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7.
8. Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002;359:579-80.
9. Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996;35:1067-74.
10. Wilson AG, De Vries N, Pociot F, Di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumour necrosis factor a promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993;177:557-60.
11. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor a associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997;40:2207-11.
12. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000;43:129-34.
13. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996;23:1725-8.
14. Chen CJ, Yen JH, Tsai WC, Wu CS, Chiang W, Tsai JJ, et al. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett 1997;55:1-3.
15. Wilson AG, Di Giovine FS, Duff GW. Genetics of tumour necrosis factor-α in autoimmune, infectious and neoplastic diseases. J Inflamm 1995;45:1-12.
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
18. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993;41:119-34.
19. Zetterquist H, Olerup O. Identification of the HLA-DRB1*04, -DRB1*07, and - DRB1*09 alleles by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Human Immunol 1992;34:64-74.
20. Olerup O, Zetterquist H. HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 1991;37:197-204.
21. Fanning GC, Bunce M, Black CM, Welsh KI. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumour necrosis factor and lymphotoxin α. Tissue Antigens 2000;50:23-31.
22. McHugh NJ, James I, Maddison P. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease. J Rheumatol 1990;17:1320-8.
23. Rudwaleit M, Tikly M, Gibson K, Pile K, Wordsworth P. HLA class II antigens associated with systemic lupus erythematosus in black South Africans. Ann Rheum Dis 1995;54:678-80.
24. Lu LY, Ding WZ, Fici D, Deulofeut R, Cheng HH, Cheu CC, et al. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997;40:1138-45.
25. Lee HS, Chung YH, Kim TG, Kim TH, Jun JB, Jung S, et al. Independent association of HLA-DR and FCgamma receptor polymorphisms in Korean patients with systemic lupus erythematosus. Rheumatology (Oxford) 2003;42:1501-7.
26. McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G, et al. Determinant spreading: lessons from animal models and human disease, Immunol Rev 1998;164:209-29.
27. Rischmueller M, Lester S, Chen Z, Champion G, Van Den BR, Beer R, et al. HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clin Exp Immunol 1998;111:365-71.
28. Skarsvag S, Hansen KE, Moen T, Eggen BM. Distributions of HLA class II alleles in autoantibody subsets among Norwegian patients with systemic lupus erythematosus. Scand J Immunol 1995;42:564-71.
29. Wilson AG, Gordon C, Di Giovine FS, De Vries N, Van de Putte LB, Emery P, et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994;24:191-5.
30. Hartung K, Ehrfeld H, Lakomek HJ, Coldewey R, Lang B, Krapf F, et al. The genetic oasis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group. Rheumatol Int 1992;11:243-9.
31. Miyagawa S, Shinohara K, Nakajima M, Kidoguchi K-I, Fujita T, Fukumoto T, et al. Polymorphism of HLA class II genes and autoimmune responses to Ro\SS-A - La\SS-B among Japanese subjects. Arthritis Rheum 1998;41:927-34.
32. Arnett FA, Hamilton RG, Reveille JD, Bias WB, Harley JB, Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 1989;32:413-19.
33. Hamilton RG, Harley JB, Bias WB, Roebber M, Reichlin M, Hochberg MC, et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988;31:496-505.
34. Graham RR, Ortmann WA, Langefeld CD, Jawaheer D, Selby SA, Rodine PR, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002;71:543-53.
35. Fujisaku A, Frank MB, Neas B, Reichlin M, Harley JB. HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J Clin Invest 1990;86:606-11.
36. Reveille JD, Macleod MJ, Whittington K, Arnett FC. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol 1991;146:3871-6.
37. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 1989;32:826-36.
38. Smolen JS, Klippel JH, Penner E, Reichlin M, Steinberg AD, Chused TM, et al. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis 1987;46:457-62.
39. Yao Z, Seelig HP, Ehrfeld H, Renz M, Hartung K, Deicher H, et al. HLA class II genes and antibodies against recombinant U1 -nRNP proteins in patients with systemic lupus erythematosus. SLE Study Group. Rheumatol Int 1994;14:63-9.
40. Galeazzi M, Sebastiani GD, Tincani A, Piette JC, Allegri F, Morozzi G, et al. HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 2000;9:47-55.
41. Granados J, Vargas-Alarcon G, Drenkard C, Andrade F, Melin-Aldana H, Alcocer-Varela J, et al. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Lupus 1997;6:57-62.
42. McHugh NJ, Maddison PJ. HLA-DR antigens and antibodies to cardiolipin in systemic lupus erythematosus. Arthritis Rheum 1989;32:1623-4.
43. Grutters JC, Sato H, Pantelidis P, Lagan AL, McGrath DS, Lammers JW, et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002;165:1119-24.
44. Tsuchiya N, Kawasaki A, Tsao BP, Komata T, Grossman JM, Tokunaga K. Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001;2:317-22.